<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: <z:chebi fb="164" ids="38867">Anesthetic</z:chebi> preconditioning appears to be a viable strategy to treat ischemic cerebral injury </plain></SENT>
<SENT sid="1" pm="."><plain>Here we investigated 1) whether the protection conferred by <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning sustains in time; 2) whether <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning diminishes <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction following <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>; and 3) whether <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore plays a crucial role in the <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Laboratory investigation </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: University research laboratory </plain></SENT>
<SENT sid="4" pm="."><plain>SUBJECTS: : Sprague-Dawley rats </plain></SENT>
<SENT sid="5" pm="."><plain>INTERVENTIONS: Rats underwent 2 hrs of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Preconditioning was elicited with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> (2.3%) for 60 mins at 24 hrs before <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The involvement of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore was determined with a <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore opener atractyloside and a specific <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore inhibitor <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>In vitro study was performed on acutely isolated mitochondria subjected to calcium overload </plain></SENT>
<SENT sid="9" pm="."><plain>MEASUREMENTS AND MAIN RESULTS: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning significantly decreased the <z:mpath ids='MPATH_124'>infarct</z:mpath> size by 35.9% (95% confidence interval 6.5-28.4, p &lt; .001) </plain></SENT>
<SENT sid="10" pm="."><plain>This reduction of injury volume was associated with a long-term improvement of neurological function according to modified neurological severity score (F = 13.6, p = .001) and sticky-tape test (F = 29.1, p &lt; .001) for 42 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Furthermore, <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning markedly protected mitochondria, as indicated by preserved respiratory chain complex activities and membrane potential, lowered <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> <z:chebi fb="17" ids="16240">hydrogen-peroxide</z:chebi> production, and attenuated <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore opening </plain></SENT>
<SENT sid="12" pm="."><plain>Isolated mitochondria also demonstrated a reduced sensitivity to Ca-induced <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore opening after pre-exposure to <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> in vitro (95% confidence interval 24.2-196.5,p = .006) </plain></SENT>
<SENT sid="13" pm="."><plain>Inhibiting <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore using <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi> resulted in protective effects similar to those seen with <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning, whereas pharmacologically opening the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore with atractyloside abrogated <z:hpo ids='HP_0000001'>all</z:hpo> the positive effects of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning and <z:chebi fb="0" ids="4031">cyclosporin A</z:chebi>, including suppression of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore opening, counteraction of mitochondria-dependent apoptotic pathway, and subsequent histological and behavioral improvements </plain></SENT>
<SENT sid="14" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="9130">Sevoflurane</z:chebi> preconditioning protects mitochondria from <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>/reperfusion injury and ameliorates long-term neurological deficits </plain></SENT>
<SENT sid="15" pm="."><plain>Inhibition of <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> permeability transition pore opening is a crucial step in mediating the neuroprotection of <z:chebi fb="0" ids="9130">sevoflurane</z:chebi> preconditioning </plain></SENT>
</text></document>